Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for adhesional small bowel obstruction
ACTRN12625000051448Phase 4Not yet recruiting
- Sponsor
- Royal Liverpool University Hospital
- Start
- Mar 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexamethasone in small bowel obstruction (SBO) (2 arms), sponsored by Royal Liverpool University Hospital. Primary endpoint: Resolution of non-malignant small bowel obstruction without surgery. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
dexamethasone
03
Conditions
small bowel obstruction (SBO)
Beyond the preview
Go deeper on ACTRN12625000051448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625000051448.